Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor

Journal of Clinical Investigation

Volumn 104, Issue 2, 1999, Pages 181-188

  Siragy, Helmy M ^a   Senbonmatsu, Takaaki ^b   Ichiki, Toshihiro ^b   Inagami, Tadashi ^b   Carey, Robert M ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CYCLIC AMP; INDOMETACIN; LOSARTAN; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTANOID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG POTENTIATION; GENE DISRUPTION; HYPERTENSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR BLOCKING; RECEPTOR GENE; SODIUM RESTRICTION; VASODILATATION;

EID: 0032713761     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6063     Document Type: Article

References (33)

1. Goodfriend, T.L., Elliott, M.E., and Catt, K.J. 1996. Angiotensin receptors and their antagonists. N. Engl. J. Med. 334:1649-1654.
2. Matsusaka, T., and Ichikawa, I. 1997. Biological functions of angiotensin and its receprors. Annu. Rev. Physiol. 59:395-412.
3. 2) receptor protein in the rat kidney. Hypertension. 30:1238-1246.
4. Shibata, K., et al. 1997. Upregulation of angiotensin type 2 receptor mRNA by angiotensin II in rat cortical cells. Biochem. Biophys. Res. Commun. 239:633-637.
5. Badr, K.F., and Jacobson, H.R. 1991. Arachidonic acid metabolites and the kidney. In The kidney, B.M. Brenner and F.C. Rector Jr., editors. W.B. Saunders. Philadelphia, PA. 584-619.
6. 2 production. J. Clin. Invest. 97:1978-1982.
7. 2α formation in conscious rats. Am. J. Physiol. 273:R1103-R1107.
8. Golub, M.S., Hori, M.T., and Tuck, M.L. 1996. Arachidonic acid metabolites in the vasculature. In Endocrinology of the vasculature. J.R. Sowers, editor. Humana Press. Totown, NJ. 357-371.
9. Ichiki, T., et al. 1995. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature. 377:748-750.
10. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest. 100:264-269.
11. Leung, K.H., et al. 1992. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes. Am. J. Hypertens. 5:648-656.
12. Porsti, I., Hecker, M., Bassenge, E., and Busse, R. 1993. Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart. Naunyn Schmiedebergs Arch. Pharmacol. 348:650-658.
13. Catalioto, R.M., Renzetti, A.R., Criscouli, M., Mizrahi, J., and Subissi, A. 1994. Angiotensins induce a release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity. Eur. J. Pharmacol. 256:93-97.
14. Catalioto, R.M., et al. 1995. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists. Eur. J. Pharmacol. 280:285-292.
15. Cox, B.E., Rosenfeld, C.R., Kalinyak, J.E., Magness, R.R., and Shaw, P.W. 1996. Tissue specific expression of vascular smooth muscle angiotensin II receptor subtypes during ovine pregnancy. Am. J. Physiol. 271:H212-H221.
16. Muirhead, E.E., et al. 1972. Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture. Circ. Res. 31(Suppl.2):161-172.
17. Murray, M.D., and Baxter, D.C. 1993. Renal toxicity of the nonsteroid anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 32:435-465.
18. McGiff, J.C., Crowshaw, K., Terragno, N.A., and Lonigro, A.J. 1970. Release of a prostaglandin-like substance into renal versus blood in response to angiotensin II. Circ. Res. 27(Suppl. 1):121-130.
19. Navar, L.G., et al. 1996. Paracrine regulation of the renal microcirculation. Physiol. Rev. 76:425-536.
20. Bottari, S.P., deGasparo, M., Steckelings, U.M., and Levans, N.R. 1993. Angiorensin II receptor subtypes: characterization, signalling mechanisms and possible physiological implications. Front. Neuroendocrinol. 14:123-171.
21. Douglas, J.G., and Hopfer, U. 1994. Novel aspects of angiotensin receptors and signal transduction in the kidney. Annu. Rev. Physiol. 56:649-669.
22. Terragno, N.A., Malik, K.U., Nasjletti, A., Terragno, D.A., and McGiff, J.C. 1976. Renal prostaglandins. Adv. Prostaglandin Thromboxane Res. 2:561-571.
23. Weber, P.C., Larsson, C., and Scherer, B. 1977. Prostaglandin E2-9-ketoreductase as a mediator of salt intake-related prostaglandin-renin interaction. Nature. 266:65-66.
24. Weber, P.C., et al. 1976. Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin endo-peroxides. Circ. Res. 39:868-874.
25. Iino, Y., and Imai, M. 1978. Effect of prostaglandins on Na transport in isolated collecting tubules. Pfugers Arch. 373:125-132.
26. Siragy, H.M., Howell, N.L., Ragsdale, N.V., and Carey, R.M. 1995. Renal interstitial fluid angiotensin modulation by anesthesia, epinephrine, sodium depletion and renin inhibition. Hypertension. 25:1021-1024.
27. Kosonen, O., Kankaanranta, H., Malo-Ranta, U., Ristimaki, A., and Moilanen, E. 1998. Inhibition by nitric oxide-releasing compounds of prosracyclin production in human endothelial cells. Br. J. Pharmacol. 125:247-254.
28. Oyekan, A.O., and McGiff, J.C. 1998. Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450-derived arachidonate metabolites. Br. J. Pharmacol. 125:1065-1073.
29. 2 and nitric oxide. Hypertension. 29:757-762.
30. Harder, D.R., Lange, A.R., Gebremedhin, D., Birks, E.K., and Roman, R.J. 1997. Cytochrome P450 merabolites of arachidonic acid as intracellular signalling molecules in vascular tissue. J. Vasc. Res. 34:237-243.
31. Alonso-Galicia, M., Sun, C.W., Falck, J.R., Harder, D.R., and Roman, R.J. 1998. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am. J. Physiol. 275:F370-F378.
32. Breyer, M.D., Jacobson, H.R., and Breyer, R.M. 1996. Functional and molecular aspects of renal prostaglandin receptors. J. Am. Soc. Nephrol. 7:8-17.
33. Parfenova, H., Hsu, P., and Leffler, C.W. 1995. Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin. J. Pharmacol. Exp. Ther. 272:44-52.